Investors

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Latest News


December 2022 Update

Race is pleased to announce the appointment of global pharmaceutical and commercial leader, Mr Damia…

Race Submits Human Ethics Application to Commence Cardioprotection Breast Cancer Trial

Danny Sharp appointed an Independent Non-Executive Director of Race

Race Oncology 2022 AGM Presentation

Race Oncology 2022 AGM Presentation by CEO Phil Lynch and CSO Dr Daniel Tillett.

Race Receives Positive Guidance on Zantrene via Pre-IND Meeting with US FDA